Feature | April 30, 2007 | Cristen C. Bolan

Vital Signs 2.0 - Nuclear Medicine at the Bedside

The term “2.0” has become the catch phrase for all things next-gen. But is it just meaningless marketing jargon or new conventional wisdom? Or might it simply represent a logical stream of consciousness – making the obvious connections and then harnessing collective intelligence?
If you peruse Web developer O’Reilly Network’s site (www.oreillynet.com), it compares the transition from Web 1.0 to 2.0 to the paradigm leap that transitioned DoubleClick to Google AdSense, personal Web Sites to blogs and content management systems to wikis.
Similarly, medical imaging is poised to take its own rational leap by leveraging the powers of bioinformatics. When I asked SNM 2006-2007 President Martin P. Sandler, M.D., what he thought would be the most significant advancements in nuclear medicine over the next five years, his response bridged the perceived gap between biology and IT – the one which separates conferences like SNM and SIIM.
Dr. Sandler said that while there will be significant advances in translational imaging systems to speed up drug development and nanoparticle technology, he firmly stated, “I think quantification is the next big breakthrough in imaging technology.”
He referred to the use of quantitative analysis in clinical practice, providing medical specialists with hard facts to back visual findings and plan treatments. Dr. Sandler noted that, “in cardiac imaging, for example, these types of tools will allow us to quantify absolute bloodflow.” Which leads us to the next logical step – bringing nuclear medicine bedside.
By employing computational power, nuclear medicine will drive personalized medicine, looking at cell activities and developing specific imaging and therapeutic interventions tailored for individuals. “I think that the biggest advancement will be bringing quantitative measurements to the bedside,” said Dr. Sandler. Could this mean Nuclear Medicine 2.0?

Related Content

Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
The Siemens Biograph Vision PET-CT system was released in mid-2018.

The Siemens Biograph Vision PET-CT system was released in mid-2018.

Feature | Nuclear Imaging | September 07, 2018 | By Dave Fornell
Nuclear imaging technology for both single photon emission computed tomography (SPECT) and positron emission tomography...
PET Imaging Agent Predicts Brain Tau Pathology, Alzheimer's Diagnosis
News | PET Imaging | September 05, 2018
Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission tomography (PET)...
Brain Study of 62,454 Scans Identifies Drives of Brain Aging
News | SPECT Imaging | August 27, 2018
In the largest known brain imaging study, scientists from five institutions evaluated 62,454 brain single photon...
Abnormal Protein Concentrations Found in Brains of Military Personnel With Suspected CTE

Researchers are using the tracer, which is injected into a patient, then seen with a PET scan, to see if it is possible to diagnose chronic traumatic encephalopathy in living patients. In this image, warmer colors indicate a higher concentration of the tracer, which binds to abnormal proteins in the brain. Credit UCLA Health.

News | PET Imaging | August 24, 2018
August 24, 2018 — In a small study of
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
Novel PET Imaging Method Could Track and Guide Type 1 Diabetes Therapy
News | PET Imaging | August 03, 2018
Researchers have discovered a new nuclear medicine test that could improve care of patients with type 1 diabetes. The...
Researchers Trace Parkinson’s Damage in the Heart
News | PET Imaging | July 17, 2018
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...